Literature DB >> 8200851

Modulation of growth factor receptors on acute myeloblastic leukemia cells by retinoic acid.

S Tohda1, M D Minden.   

Abstract

The effects of retinoic acid (RA) on the proliferation of acute myeloblastic leukemia (AML) cells were studied. AML samples were divided into three groups. Namely, RA stimulated blast colony formation by AML samples in group A and inhibited that by the samples in group B, regardless of added growth factors. For the samples in group C, RA inhibited the colonies formed by granulocyte colony-stimulating factor (G-CSF) but stimulated those by granulocyte macrophage CSF (GM-CSF). To investigate the mechanism involved, the effects of RA on growth factor receptors on AML cells were examined by flow cytometry using fluorolabeled ligands. For the samples in groups A and B, RA affected neither G-CSF receptor (GR) nor GM-CSF receptor (GMR). For the samples in group C, exposure to 10(-7) M RA for 1 day clearly increased GMR, but did not affect GR. This finding supports the hypothesis that the increase of GMR is one of the causes of the stimulative effects of RA on cells cultured with GM-CSF in group C.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200851      PMCID: PMC5919469          DOI: 10.1111/j.1349-7006.1994.tb02370.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

1.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Authors:  S Castaigne; C Chomienne; M T Daniel; P Ballerini; R Berger; P Fenaux; L Degos
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

2.  Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.

Authors:  C Wang; P Koistinen; G S Yang; D E Williams; S D Lyman; M D Minden; E A McCulloch
Journal:  Leukemia       Date:  1991-06       Impact factor: 11.528

3.  Comparison of the effects of all-trans and cis-retinoic acid on the blast stem cells of acute myeloblastic leukemia in culture.

Authors:  S Tohda; J E Curtis; E A McCulloch; M D Minden
Journal:  Leukemia       Date:  1992-07       Impact factor: 11.528

4.  Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia.

Authors:  M D Minden; R N Buick; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

Review 5.  Retinobenzoic acids and nuclear retinoic acid receptors.

Authors:  Y Hashimoto
Journal:  Cell Struct Funct       Date:  1991-04       Impact factor: 2.212

6.  Structure and expression of the GM-CSF receptor alpha and beta chain genes in human leukemia.

Authors:  M A Brown; N M Gough; T A Willson; S Rockman; C G Begley
Journal:  Leukemia       Date:  1993-01       Impact factor: 11.528

7.  Dexamethasone and retinoic acid regulate the expression of epidermal growth factor receptor mRNA by distinct mechanisms.

Authors:  K C Oberg; G Carpenter
Journal:  J Cell Physiol       Date:  1991-11       Impact factor: 6.384

8.  Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia.

Authors:  S Tohda; M D Minden; E A McCulloch
Journal:  Leukemia       Date:  1991-11       Impact factor: 11.528

9.  NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

Authors:  M Lanotte; V Martin-Thouvenin; S Najman; P Balerini; F Valensi; R Berger
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

10.  Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.

Authors:  D P Gearing; J A King; N M Gough; N A Nicola
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  1 in total

1.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.